Xponance’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-813
| Closed | -$8.29K | – | 1531 |
|
|
2025
Q1 | $8.29K | Buy |
813
+20
| +3% | +$204 | ﹤0.01% | 1441 |
|
|
2024
Q4 | $11.1K | Buy |
793
+73
| +10% | +$1.02K | ﹤0.01% | 1439 |
|
|
2024
Q3 | $14K | Sell |
720
-44
| -6% | -$858 | ﹤0.01% | 1385 |
|
|
2024
Q2 | $14.2K | Buy |
+764
| New | +$14.2K | ﹤0.01% | 1313 |
|
|
2023
Q2 | – | Sell |
-689
| Closed | -$7.27K | – | 1278 |
|
|
2023
Q1 | $7.27K | Hold |
689
| – | – | ﹤0.01% | 1234 |
|
|
2022
Q4 | $23.4K | Buy |
689
+11
| +2% | +$373 | ﹤0.01% | 1210 |
|
|
2022
Q3 | $33K | Buy |
+678
| New | +$33K | ﹤0.01% | 1166 |
|
|
2021
Q4 | – | Sell |
-1,376
| Closed | -$371K | – | 1187 |
|
|
2021
Q3 | $371K | Sell |
1,376
-46
| -3% | -$12.4K | 0.01% | 995 |
|
|
2021
Q2 | $366K | Buy |
1,422
+142
| +11% | +$36.5K | 0.01% | 1022 |
|
|
2021
Q1 | $384K | Buy |
1,280
+26
| +2% | +$7.8K | 0.01% | 886 |
|
|
2020
Q4 | $320K | Sell |
1,254
-2
| -0.2% | -$510 | 0.01% | 933 |
|
|
2020
Q3 | $312K | Buy |
1,256
+185
| +17% | +$46K | 0.01% | 843 |
|
|
2020
Q2 | $372K | Buy |
+1,071
| New | +$372K | 0.01% | 748 |
|